Enma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 10-01-2025
- Paid Up Capital ₹ 2.00 Cr
as on 10-01-2025
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.60 M
as on 10-01-2025
- Satisfied Charges ₹ 1.78 Cr
as on 10-01-2025
- Revenue -11.18%
(FY 2021)
- Profit 20.95%
(FY 2021)
- Ebitda -7.68%
(FY 2021)
- Net Worth 15.21%
(FY 2021)
- Total Assets 6.97%
(FY 2021)
About Enma Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹3.60 M. The company has closed loans amounting to ₹1.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Merybal Barnabas, Rajalingam Vaithilingam, Malini Merybal, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397TN2004PTC053088
- Company No.
053088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Enma Pharmaceuticals Private Limited offer?
Enma Pharmaceuticals Private Limited offers a wide range of products and services, including Multivitamin Tablets & Capsules, Iron Folic Acid Tablet.
Who are the key members and board of directors at Enma Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Merybal Barnabas  | Additional Director | 16-Apr-2022 | Current |
| Rajalingam Vaithilingam | Director | 12-Sep-2013 | Current |
| Malini Merybal | Additional Director | 31-Mar-2017 | Current |
| Nivetha Immanuel | Additional Director | 09-Dec-2019 | Current |
Financial Performance of Enma Pharmaceuticals.
Enma Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.18% decrease. The company also saw a substantial improvement in profitability, with a 20.95% increase in profit. The company's net worth Soared by an impressive increase of 15.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enma Pharmaceuticals?
In 2021, Enma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Clinician India Private LimitedActive 6 years 8 months
Merybal Barnabas and Malini Merybal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Sep 2021 | ₹3.60 M | Open |
Tamilnad Mercantile Bank Limited Creation Date: 11 Jun 2020 | ₹1.30 M | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 14 Feb 2019 | ₹6.50 M | Satisfied |
How Many Employees Work at Enma Pharmaceuticals?
Enma Pharmaceuticals has a workforce of 12 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enma Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
